{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T15:43:55Z","timestamp":1780760635846,"version":"3.54.1"},"reference-count":40,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["molpharm.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Pharmacology"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1124\/mol.118.115048","type":"journal-article","created":{"date-parts":[[2019,1,29]],"date-time":"2019-01-29T19:36:12Z","timestamp":1548790572000},"page":"408-417","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Monod-Wyman-Changeux Allosteric Shift Analysis in Mutant \u03b11\u03b23\u03b32L GABAA Receptors Indicates Selectivity and Crosstalk among Intersubunit Transmembrane Anesthetic Sites"],"prefix":"10.1016","volume":"95","author":[{"given":"Andrea","family":"Szabo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anahita","family":"Nourmahnad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Halpin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart A.","family":"Forman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/mol.118.115048_bib1","doi-asserted-by":"crossref","first-page":"36275","DOI":"10.1074\/jbc.M105240200","article-title":"\u03b3-aminobutyric acid type A receptors","volume":"276","author":"Baumann","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.118.115048_bib2","doi-asserted-by":"crossref","first-page":"11031","DOI":"10.1073\/pnas.94.20.11031","article-title":"\u03b3-aminobutyric acid type A receptor is influenced by a single amino acid","volume":"94","author":"Belelli","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/mol.118.115048_bib3","series-title":"Data Reduction and Error Analysis for the Physical Sciences","author":"Bevington","year":"2002"},{"key":"10.1124\/mol.118.115048_bib4","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1007\/s40263-017-0463-7","article-title":"The role of GABA receptor agonists in anesthesia and sedation","volume":"31","author":"Brohan","year":"2017","journal-title":"CNS Drugs"},{"key":"10.1124\/mol.118.115048_bib5","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-28754-7","article-title":"Enhanced GABAergic actions resulting from the coapplication of the steroid 3\u03b1-hydroxy-5\u03b1-pregnane-11,20-dione (alfaxalone) with propofol or diazepam","volume":"8","author":"Cao","year":"2018","journal-title":"Sci Rep"},{"key":"10.1124\/mol.118.115048_bib6","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.1016\/S0006-3495(99)77089-X","article-title":"\u03b11\u03b22\u03b32 \u03b3-aminobutyric acid type A receptor revealed by mutation of the conserved M2 leucine","volume":"77","author":"Chang","year":"1999","journal-title":"Biophys J"},{"key":"10.1124\/mol.118.115048_bib7","doi-asserted-by":"crossref","first-page":"19343","DOI":"10.1074\/jbc.M113.479725","article-title":"Specificity of intersubunit general anesthetic-binding sites in the transmembrane domain of the human \u03b11\u03b23\u03b32 \u03b3-aminobutyric acid type A (GABAA) receptor","volume":"288","author":"Chiara","year":"2013","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.118.115048_bib8","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1097\/ALN.0b013e3181b55fae","article-title":"\u03b3-Amino butyric acid type A receptor mutations at \u03b22N265 alter etomidate efficacy while preserving basal and agonist-dependent activity","volume":"111","author":"Desai","year":"2009","journal-title":"Anesthesiology"},{"key":"10.1124\/mol.118.115048_bib9","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1111\/bph.12507","article-title":"\u03b11\u03b23\u03b4 \u03b11\u03b23\u03b32L GABAA receptors","volume":"171","author":"Feng","year":"2014","journal-title":"Br J Pharmacol"},{"key":"10.1124\/mol.118.115048_bib10","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1097\/ACO.0b013e328354feea","article-title":"Monod-Wyman-Changeux allosteric mechanisms of action and the pharmacology of etomidate","volume":"25","author":"Forman","year":"2012","journal-title":"Curr Opin Anaesthesiol"},{"key":"10.1124\/mol.118.115048_bib11","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/bs.mie.2018.01.014","article-title":"Combining mutations and electrophysiology to map anesthetic sites on ligand-gated ion channels","volume":"602","author":"Forman","year":"2018","journal-title":"Methods Enzymol"},{"key":"10.1124\/mol.118.115048_bib12","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1213\/ANE.0000000000001368","article-title":"\u03b3-aminobutyric acid type A receptors reveals a potential for targeting receptor subtypes","volume":"123","author":"Forman","year":"2016","journal-title":"Anesth Analg"},{"key":"10.1124\/mol.118.115048_bib13","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/978-1-61779-334-9_17","article-title":"Mutations in the GABAA receptor that mimic the allosteric ligand etomidate","volume":"796","author":"Forman","year":"2012","journal-title":"Methods Mol Biol"},{"key":"10.1124\/mol.118.115048_bib14","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1124\/mol.117.111435","article-title":"High constitutive activity accounts for the combination of enhanced direct activation and reduced potentiation in mutated GABAA receptors","volume":"93","author":"Germann","year":"2018","journal-title":"Mol Pharmacol"},{"key":"10.1124\/mol.118.115048_bib15","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1097\/ALN.0b013e3182567df3","article-title":"\u03b11\u03b22\u03b32 \u03b3-aminobutyric acid type A receptors contribute equally and noncooperatively to modulation of channel gating","volume":"116","author":"Guitchounts","year":"2012","journal-title":"Anesthesiology"},{"key":"10.1124\/mol.118.115048_bib16","doi-asserted-by":"crossref","first-page":"27456","DOI":"10.1074\/jbc.M114.581728","article-title":"Multiple propofol-binding sites in a \u03b3-aminobutyric acid type A receptor (GABAAR) identified using a photoreactive propofol analog","volume":"289","author":"Jayakar","year":"2014","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.118.115048_bib17","doi-asserted-by":"crossref","first-page":"23432","DOI":"10.1074\/jbc.M115.672006","article-title":"\u03b11\u03b23\u03b32 \u03b3-aminobutyric acid type A (GABAA \u03b3+-\u03b2\u2212 interface","volume":"290","author":"Jayakar","year":"2015","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.118.115048_bib18","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1124\/mol.53.3.530","article-title":"\u03b3-aminobutyric acid type A receptor distinct from that for isoflurane","volume":"53","author":"Krasowski","year":"1998","journal-title":"Mol Pharmacol"},{"key":"10.1124\/mol.118.115048_bib19","doi-asserted-by":"crossref","first-page":"11599","DOI":"10.1523\/JNEUROSCI.3467-06.2006","article-title":"Identification of a GABAA receptor anesthetic binding site at subunit interfaces by photolabeling with an etomidate analog","volume":"26","author":"Li","year":"2006","journal-title":"J Neurosci"},{"key":"10.1124\/mol.118.115048_bib20","doi-asserted-by":"crossref","first-page":"5446","DOI":"10.1111\/bph.12861","article-title":"The neurosteroid 5\u03b2-pregnan-3\u03b1-ol-20-one enhances actions of etomidate as a positive allosteric modulator of \u03b11\u03b22\u03b32L GABAA receptors","volume":"171","author":"Li","year":"2014","journal-title":"Br J Pharmacol"},{"key":"10.1124\/mol.118.115048_bib21","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1097\/ALN.0b013e318289bcd3","article-title":"\u03b11\u03b22\u03b32L \u03b3-aminobutyric acid type A receptors activated by either \u03b3-aminobutyric acid or allosteric agonists","volume":"118","author":"Li","year":"2013","journal-title":"Anesthesiology"},{"key":"10.1124\/mol.118.115048_bib22","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.neuropharm.2016.01.003","article-title":"Functional sites involved in modulation of the GABAA receptor channel by the intravenous anesthetics propofol, etomidate and pentobarbital","volume":"105","author":"Maldifassi","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.1124\/mol.118.115048_bib23","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/38738","article-title":"Sites of alcohol and volatile anaesthetic action on GABAA and glycine receptors","volume":"389","author":"Mihic","year":"1997","journal-title":"Nature"},{"key":"10.1124\/mol.118.115048_bib24","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1097\/ALN.0000000000001390","article-title":"Tryptophan and cysteine mutations in M1 helices of \u03b11\u03b23\u03b32L \u03b3-aminobutyric acid type A receptors indicate distinct intersubunit sites for four intravenous anesthetics and one orphan site","volume":"125","author":"Nourmahnad","year":"2016","journal-title":"Anesthesiology"},{"key":"10.1124\/mol.118.115048_bib25","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.neuropharm.2008.07.045","article-title":"GABAA receptors: subtypes provide diversity of function and pharmacology","volume":"56","author":"Olsen","year":"2009","journal-title":"Neuropharmacology"},{"key":"10.1124\/mol.118.115048_bib26","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.39383","article-title":"Cryo-EM structure of the benzodiazepine-sensitive \u03b11\u03b21\u03b32S tri-heteromeric GABAA receptor in complex with GABA","volume":"7","author":"Phulera","year":"2018","journal-title":"eLife"},{"key":"10.1124\/mol.118.115048_bib27","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1097\/ALN.0b013e31823d0c36","article-title":"\u03b11\u03b22\u03b32 \u03b3-aminobutyric acid type A receptors","volume":"116","author":"Ruesch","year":"2012","journal-title":"Anesthesiology"},{"key":"10.1124\/mol.118.115048_bib28","doi-asserted-by":"crossref","first-page":"20982","DOI":"10.1074\/jbc.M400472200","article-title":"\u03b11\u03b22\u03b32L GABAA receptors accounts for both direct activation and agonist modulation","volume":"279","author":"R\u00fcsch","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.118.115048_bib29","doi-asserted-by":"crossref","first-page":"8411","DOI":"10.1523\/JNEUROSCI.22-19-08411.2002","article-title":"Coupled and uncoupled gating and desensitization effects by pore domain mutations in GABAA receptors","volume":"22","author":"Scheller","year":"2002","journal-title":"J Neurosci"},{"key":"10.1124\/mol.118.115048_bib30","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1124\/mol.118.113464","article-title":"Analysis of GABAA receptor activation by combinations of agonists acting at the same or distinct binding sites","volume":"95","author":"Shin","year":"2019","journal-title":"Mol Pharmacol"},{"key":"10.1124\/mol.118.115048_bib31","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1124\/mol.117.110403","article-title":"Propofol is an allosteric agonist with multiple binding sites on concatemeric ternary GABAA receptors","volume":"93","author":"Shin","year":"2018","journal-title":"Mol Pharmacol"},{"key":"10.1124\/mol.118.115048_bib32","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1124\/mol.117.109595","article-title":"The actions of drug combinations on the GABAA receptor manifest as curvilinear isoboles of additivity","volume":"92","author":"Shin","year":"2017","journal-title":"Mol Pharmacol"},{"key":"10.1124\/mol.118.115048_bib33","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1471-2210-3-13","article-title":"\u03b3-aminobutyric acidA \u03b11\u03b22\u03b32","volume":"3","author":"Siegwart","year":"2003","journal-title":"BMC Pharmacol"},{"key":"10.1124\/mol.118.115048_bib34","doi-asserted-by":"crossref","first-page":"40224","DOI":"10.1074\/jbc.R112.386664","article-title":"Structure, function, and modulation of GABAA receptors","volume":"287","author":"Sigel","year":"2012","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.118.115048_bib35","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1124\/mol.118.113787","article-title":"Applying the Monod-Wyman-Changeux allosteric activation model to pseudo-steady-state responses from GABAA receptors","volume":"95","author":"Steinbach","year":"2019","journal-title":"Mol Pharmacol"},{"key":"10.1124\/mol.118.115048_bib36","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1124\/mol.108.050500","article-title":"Tryptophan mutations at azi-etomidate photo-incorporation sites on \u03b11 \u03b22 subunits enhance GABAA receptor gating and reduce etomidate modulation","volume":"74","author":"Stewart","year":"2008","journal-title":"Mol Pharmacol"},{"key":"10.1124\/mol.118.115048_bib37","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1038\/sj.bjp.0703504","article-title":"Tryptophan scanning mutagenesis in TM2 of the GABAA \u03b1 subunit: effects on channel gating and regulation by ethanol","volume":"131","author":"Ueno","year":"2000","journal-title":"Br J Pharmacol"},{"key":"10.1124\/mol.118.115048_bib38","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/sj.bjp.0702563","article-title":"Subunit mutations affect ethanol actions on GABAA Xenopus oocytes","volume":"127","author":"Ueno","year":"1999","journal-title":"Br J Pharmacol"},{"key":"10.1124\/mol.118.115048_bib39","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1038\/81800","article-title":"Benzodiazepines act on GABAA receptors via two distinct and separable mechanisms","volume":"3","author":"Walters","year":"2000","journal-title":"Nat Neurosci"},{"key":"10.1124\/mol.118.115048_bib40","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0154031","article-title":"Correction for inhibition leads to an allosteric co-agonist model for pentobarbital modulation and activation of \u03b11\u03b23\u03b32L GABAA receptors","volume":"11","author":"Ziemba","year":"2016","journal-title":"PLoS One"}],"container-title":["Molecular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X24008873?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X24008873?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/mol.118.115048","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T10:28:43Z","timestamp":1739960923000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026895X24008873"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":40,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["S0026895X24008873"],"URL":"https:\/\/doi.org\/10.1124\/mol.118.115048","relation":{},"ISSN":["0026-895X"],"issn-type":[{"value":"0026-895X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Monod-Wyman-Changeux Allosteric Shift Analysis in Mutant \u03b11\u03b23\u03b32L GABAA Receptors Indicates Selectivity and Crosstalk among Intersubunit Transmembrane Anesthetic Sites","name":"articletitle","label":"Article Title"},{"value":"Molecular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/mol.118.115048","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}